TransMedics (TMDX) Shares Outstanding (Weighted Average) (2018 - 2026)

TransMedics' Shares Outstanding (Weighted Average) history runs 9 years deep, the most recent figure standing at $34.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.96% year-over-year to $34.4 million; the TTM figure through Mar 2026 stood at $34.4 million (up 1.96% YoY), while the FY2025 annual figure was $34.0 million, up 2.3% from the prior year.
• Shares Outstanding (Weighted Average) was $34.4 million for Q1 2026 at TransMedics, up from $34.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $34.4 million in Q1 2026 to a low of $28.0 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $32.2 million across 5 years, with a median of $32.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) advanced 1.31% in 2022, then climbed 15.79% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.6 million in 2022, then increased by 10.02% to $32.5 million in 2023, then gained by 2.19% to $33.2 million in 2024, then climbed by 2.3% to $34.0 million in 2025, then grew by 1.15% to $34.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $34.4 million (Q1 2026), $34.0 million (Q4 2025), and $33.9 million (Q3 2025), per Business Quant data.